Research Journal of Biological Sciences

Year: 2011
Volume: 6
Issue: 10
Page No. 496 - 506

Effect of Carprofen on Pentylenetetrazole-Induced Seizure Threshold in Mice

Authors : KhayatnouriMirhadi

References

Akarsu, E.S., S. Ozdayi, E. Algan and F. Ulupinar, 2006. The neuronal excitability time-dependently changes after lipopolysaccharide administration in mice: Possible role of cyclooxygenase-2 induction. Epilepsy Res., 71: 181-187.
CrossRef  |  

Baik, E.J., E.J. Kim, S.H. Lee and C.H. Moon, 1999. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizures and neuronal cell death in the hippocampus. Brain Res., 843: 118-129.
CrossRef  |  

Bidmon, H.J., E.J. Speckmann and K.J. Zilles, 2009. Seizure semiology, neurotransmitter receptors and cellular-stress responses in pentylenetetrazole models of epilepsy. Eur. Neuro. Rev., 4: 76-80.

Chen, C. and N.G. Bazan, 2005. Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. J. Neurophysiol., 93: 929-941.
CrossRef  |  

Choi, S.H., S. Aid and F. Bosetti, 2009. The distinct roles of cyclooxygenase-1 and-2 in neuroinflammation: Implications for translational research. Trends Pharmacol. Sci., 30: 174-181.

Desjardins, P., A. Sauvageau, A. Bouthillier, D. Navarro, A.S. Hazell, C. Rose and R.F. Butterworth, 2003. Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis. Neurochem. Int., 42: 299-303.
Direct Link  |  

Dhir, A. and S.K. Kulkarni, 2006. Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice. Inflammopharmacology, 14: 222-225.
PubMed  |  

Dhir, A., K.K. Akula and S.K. Kulkarni, 2008. Rofecoxib potentiates the anticonvulsant effect of topiramate. Inflammopharmacology, 16: 83-86.
PubMed  |  

Dhir, A., P.S. Naidu and S.K. Kulkarni, 2005. Protective effect of naproxen, a non-selective COX-inhibitor on PTZ-induced kindling in mice. Clin. Exp. Pharmacol. Physiol., 32: 574-584.
PubMed  |  

Dhir, A., P.S. Naidu and S.K. Kulkarni, 2006. Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)- induced convulsions: Possible mechanism of action. Prog. Neuropsychopharmacol. Biol. Psychiatry, 30: 1478-1485.
PubMed  |  

Dhir, A., P.S. Naidu and S.K. Kulkarni, 2006. Effect of cyclooxygenase inhibitors on various animal models (picrotoxin, bicuculine and maximal electroshock-induced convulsions, possible mechanism of action. Indian J. Exp. Biol., 44: 286-291.
PubMed  |  

Dhir, A., P.S. Naidu and S.K. Kulkarni, 2006. Effect of rofecoxib, a cyclooxygenase-2 (COX-2) inhibitor, on various biochemical parameters of brain associated with pentylenetetrazol (PTZ)-induced chemical kindling in mice. Fundam. Clin. Pharmacol., 20: 255-261.
Direct Link  |  

Gobbo, O.L. and S.M. O'Mara, 2004. Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration. Neuroscience, 125: 317-327.
PubMed  |  

Jung, K.H., K. Chu, S.T. Lee, J. Kim and D.I. Sinn et al., 2006. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol. Dis., 23: 237-246.
PubMed  |  

Kawaguchi, K., R.W. Hickey, M.E. Rose, L. Zhu, J. Chen and S.H. Graham, 2005. Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus. Brain Res., 1050: 130-137.
PubMed  |  

Kim, H.J., J.I. Chung, S.H. Lee, Y.S. Jung, C.H. Moon and E.J. Baik, 2008. Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: The mechanism of proconvulsant effects of COX-2 inhibitors. Brain Res., 1193: 153-161.
Direct Link  |  

Kunz, T. and E.H. Oliw, 2001. Nimesulide aggravates kainic acid-induced seizures in the rat. Pharmacol. Toxicol., 88: 271-276.
Direct Link  |  

Kunz, T. and E.H. Oliw, 2001. The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur. J. Neurosci., 13: 569-575.
PubMed  |  

Kunz, T., N. Marklund, L. Hillered and E.H. Oliw, 2005. Assessment of the effects of the cyclooxygenase-2 inhibitor rofecoxib on visuospatial learning and hippocampal cell death following kainate-induced seizures in the rat. Cogn. Brain Res., 25: 826-832.
CrossRef  |  

Kyrkanides, S., A.H. Moore, J.A. Olschowka, J.C. Daeschner, J.P. Williams, J.T. Hansen and M.K. O'Banion, 2002. Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Mol. Brain Res., 104: 159-169.
PubMed  |  

Liantonio, A., V. Giannuzzi, A. Picollo, E. Babini, M. Pusch and D.C. Camerino, 2007. Niflumic acid inhibits chloride conductance of rat skeletal muscle by direct inhibiting the CLC-1 channel and by increasing intracellular calcium. Br. J. Pharmacol., 150: 235-247.
PubMed  |  

Malykhina, A.P., F. Shoeb and H.I. Akbarali, 2002. Fenamate-induced enhancement of heterologously expressed HERG currents in Xenopus oocytes. Eur. J. Pharmacol., 11: 269-277.
PubMed  |  Direct Link  |  

Minghetti, L. and M. Pocchiari, 2007. Cyclooxygenase-2, prostaglandin E2 and microglial activation in prion diseases. Int. Rev. Neurobiol., 82: 265-275.
PubMed  |  

Okada, K., T. Yuhi, S. Tsuji and U. Yamashita, 2001. Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible El mice was increased after seizure. Brain Res., 894: 332-335.
PubMed  |  

Park, S.Y., T.H. Kim, H.I. Kim, Y.K. Shin, C.S. Lee, M. Park and J.H. Song, 2007. Celecoxib inhibits Nap currents in rat dorsal root ganglion neurons. Brain Res., 1148: 53-61.

Peretz, A., N. Degani, R. Nachman, Y. Uziyel, G. Gibor, D. Shabat and B. Attali, 2005. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol. Pharmacol., 67: 1053-1066.
PubMed  |  

Perrone, M.G., A. Scilimati, L. Simone and P. Vitale, 2010. Selective COX-1 inhibition: A therapeutic target to be reconsidered. Curr. Med. Chem., 17: 3769-3805.
PubMed  |  

Rantala, H., R. Tarkka and M. Uhari, 2001. Systematic review of the role of prostaglandins and their synthase inhibitors with respect to febrile seizures. Epilepsy Res., 46: 251-257.
PubMed  |  

Reeta, K., P.K. Mediratta, P. Mahajan and K.K. Sharma, 2003. Differential effect of cyclooxygenase-2 prefering inhibitors on electrically- and chemically-induced seizures in mice. Indian J. Physiol. Pharmacol., 44: 471-475.
PubMed  |  

Rimoli, M.G., E. Russo, M. Cataldi, R. Citraro and P. Ambrosino et al., 2009. T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin. Neuropharmacology, 56: 637-646.
PubMed  |  

Salvemini, D., 1997. Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol. Life Sci., 53: 576-582.
PubMed  |  

Samini, M., H. Shafaroodi, V. Sehat and S. Allahdini, 2005. Comparison of the effects of lindane and permethrin on pentylenetetrazole-induced clonic seizure in mice. Online J. Vet. Res., 9: 37-47.
Direct Link  |  

Shafaroodi, H., M. Samini, L. Moezi, H. Homayoun and H. Sadeghipour et al., 2004. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology, 47: 390-400.
PubMed  |  

Shafiq, N., S. Malhotra and P. Pandhi, 2003. Anticonvulsant action of celecoxib (alone and in combination with sub-threshold dose of phenytoin) in electroshock induced convulsion. Methods Find Exp. Clin. Pharmacol., 25: 87-90.
PubMed  |  

Shaw, K.N., S. Commins and S.M. O'Mara, 2003. Deficits in spatial learning and synaptic plasticity induced by the rapid and competitive broad-spectrum cyclooxygenase inhibitor ibuprofen are reversed by increasing endogenous brain-derived neurotrophic factor. Eur. J. Neurosci., 17: 2438-2446.
PubMed  |  

Takemiya, T., K. Suzuki, H. Sugiura, S. Yasuda, K. Yamagata, Y. Kawakami and E. Maru, 2003. Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Lipid Mediators, 71: 205-216.
CrossRef  |  

Tandon, M., K. Anuradha and P. Pandhi, 2003. Evaluation of antiepileptic activity of aspirin in combination with newer antiepileptic lamotrigine in mice. Method Find Exp. Clin. Pharmacol., 25: 607-610.
PubMed  |  

Tu, B. and N.G. Bazan, 2003. Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp. Neurol., 179: 167-175.
CrossRef  |  PubMed  |  

Voilley, N., J. de Weille, J. Mamet and M. Lazdunski, 2001. Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J. Neurosci., 21: 8026-8033.
Direct Link  |  

Yoshikawa, K., Y. Kita, K. Kishimoto and T. Shimizu, 2006. Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure: Dual phase regulation and differential involvement of cox-1 and cox. J. Biol. Chem., 281: 14663-14669.
CrossRef  |  

Yuhas, Y., A. Weizman, A. Vanichkin and S. Ashkenazi, 2005. Involvement of prostaglandins in an animal model of Shigella-related seizures. J. Neuroimmunol., 168: 34-39.
PubMed  |  

Zandieh, A., F. Maleki, A. Hajimirzabeigi, B. Zandieh, O. Khalilzadeh and A.R. Dehpour, 2010. Anticonvulsant effect of celecoxib on pentylenetetrazoleinduced convulsion: Modulation by NO pathway. Acta Neurobiol. Exp., 70: 390-397.
PubMed  |  

Zhang, H., R. Sun, G. Lei, L. Yang and C. Liu, 2009. Cyclooxygenase-2 inhibitor inhibits the hippocampal synaptic reorganization by inhibiting MAPK/ERK activity and modulating GABAergic transmission in pilocarpine-induced status epilepticus rats. Med. Chem. Res., 18: 71-90.
Direct Link  |  

Zhang, Y., J. Tao, H. Huang, G. Ding, Y. Cheng and W. Sun, 2007. Effects of celecoxib on voltage-gated calcium channel currents in rat pheochromocytoma (PC12) cells. Pharmacol. Res., 56: 267-274.
PubMed  |  

Design and power by Medwell Web Development Team. © Medwell Publishing 2024 All Rights Reserved